World Alzheimer Report 2014: Dementia and Risk Reduction

Tags: , ,


Dementia, including Alzheimer’s disease, remains one of the biggest global public health challenges facing our generation. The number of people living with dementia worldwide today is estimated at 44 million, set to almost double by 2030 and more than triple by 2050. The global cost of dementia was estimated in 2010 at US $604 billion, and this is only set to rise.

Given this epidemic scale, and with no known cure, it’s crucial that we look at what we can do to reduce the risk or delay the onset of developing the disease. Alzheimer’s Disease International (ADI) believes that Alzheimer’s disease and other forms of dementia must become a national and international public health priority. Governments must develop adequate strategies to deal with the epidemic holistically – including tackling both reduction in risk for future generations, and adequately caring for people living with the condition and supporting their friends and family.

As the only worldwide international federation of Alzheimer associations and global voice on dementia, and the largest international provider of specialist dementia care, ADI is committed to changing the way the world thinks about dementia.

For a copy of the report, visit here.


OECD Indicators Health at a Glance 2013


Health at a Glance 2013 presents the trends and influences shaping health status, services and policies in OECD countries and the BRIICS. Although indicators such as life expectancy or infant mortality suggest that things are improving overall, inequalities in wealth, education and other social indicators still have a significant impact on health status and access to health services. These health disparities may be explained by differences in living and working conditions, as well as differences that show up in the health-related lifestyle data presented here (e.g., smoking, harmful alcohol drinking, physical inactivity, and obesity).

Health expenditures show considerable variations across countries, in terms of spending per capita, as a share of GDP and recent trends. On average across the OECD, per capita health spending grew by 4.1% annually in real terms over 2000-2009, but this slowed to 0.2% in 2009-10 and 2010-11 as many countries reduced health spending to help cut budget deficits and government debt, especially in Europe. Countries outside of Europe have continued to see health spending grow, albeit at a reduced pace in many cases, notably in Canada and the United States.

Different areas of spending have been affected in different ways: in 2010-11, spending on pharmaceuticals and prevention dropped by 1.7%, while hospital costs rose by 1.0%.


International Profiles of Health Care Systems 2013


This publication presents overviews of the health care systems of Australia, Canada, Denmark, England, France, Germany, Japan, Italy, the Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United States. Each overview covers health insurance, public and private financing, health system organization and governance, health care quality and coordination, disparities, efficiency and integration, use of information technology and evidence-based practice, cost containment, and recent reforms and innovations.

In addition, summary tables provide data on a number of key health system characteristics and performance indicators, including overall health care spending, hospital spending and utilization, health care access, patient safety, care coordination, chronic care management, disease prevention, capacity for quality improvement, and public views.